A
Menu
February 29, 2024 article Open access

Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a randomised, open-label, phase 3 trial

The Lancet Healthy Longevity

DOI: 10.1016/s2666-7568(23)00284-2 Full text (OA) OpenAlex

Authors 0

  1. Author list not loaded yet.

Cited by 2 stored of 12

2 results

References 0